Click on image to view larger version.

Figure 1 Cumulative follow-up costs for the paclitaxel and control stent groups for the overall trial population (A) and the subgroup assigned to clinical follow-up alone (B). Mean cost differences at 6, 9, and 12 months are indicated in the boxes.